EPIWORLD Publishes Updated Board Composition and Committee Assignments

Bulletin Express06-22

Epiworld International Co., Ltd. disclosed the latest structure of its Board of Directors and subsidiary committees on 22 June 2026. The Board now comprises seven members: two executive directors, two non-executive directors and three independent non-executive directors.

Executive directors are Dr. Zhao Jianhui and Ms. Pan Menghan. The non-executive cohort consists of Ms. Xie Jieping and Ms. Guo Danxia. Independent oversight is provided by Dr. Kang Junyong, Dr. Liao Yi and Dr. Su Xinlong.

Committee leadership and membership have been clarified:

• Audit Committee – chaired by Dr. Su Xinlong, with Dr. Kang Junyong and Dr. Liao Yi serving as members. • Remuneration Committee – chaired by Dr. Kang Junyong; members include Ms. Pan Menghan and Dr. Su Xinlong. • Nomination Committee – chaired by Dr. Liao Yi and joined by Dr. Kang Junyong and Dr. Su Xinlong. • Strategy Committee – chaired by Dr. Zhao Jianhui, with Ms. Guo Danxia serving as a member.

The announcement underscores EPIWORLD’s adherence to corporate governance practices by delineating clear responsibilities across its audit, remuneration, nomination and strategy functions. The disclosure satisfies Hong Kong listing requirements for transparency regarding board roles and committee composition.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1116120637?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 23:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116120637","market":"us","top_or_hot":-1,"title":"EPIWORLD Publishes Updated Board Composition and Committee Assignments","media":"Bulletin Express","content":"<p>Epiworld International Co., Ltd. disclosed the latest structure of its Board of Directors and subsidiary committees on 22 June 2026. The Board now comprises seven members: two executive directors, two non-executive directors and three independent non-executive directors.</p>\n<p>Executive directors are Dr. Zhao Jianhui and Ms. Pan Menghan. The non-executive cohort consists of Ms. Xie Jieping and Ms. Guo Danxia. Independent oversight is provided by Dr. Kang Junyong, Dr. Liao Yi and Dr. Su Xinlong.</p>\n<p>Committee leadership and membership have been clarified:</p>\n<p>• Audit Committee – chaired by Dr. Su Xinlong, with Dr. Kang Junyong and Dr. Liao Yi serving as members.  \n• Remuneration Committee – chaired by Dr. Kang Junyong; members include Ms. Pan Menghan and Dr. Su Xinlong.  \n• Nomination Committee – chaired by Dr. Liao Yi and joined by Dr. Kang Junyong and Dr. Su Xinlong.  \n• Strategy Committee – chaired by Dr. Zhao Jianhui, with Ms. Guo Danxia serving as a member.</p>\n<p>The announcement underscores EPIWORLD’s adherence to corporate governance practices by delineating clear responsibilities across its audit, remuneration, nomination and strategy functions. The disclosure satisfies Hong Kong listing requirements for transparency regarding board roles and committee composition.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EPIWORLD Publishes Updated Board Composition and Committee Assignments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEPIWORLD Publishes Updated Board Composition and Committee Assignments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-22 23:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Epiworld International Co., Ltd. disclosed the latest structure of its Board of Directors and subsidiary committees on 22 June 2026. The Board now comprises seven members: two executive directors, two non-executive directors and three independent non-executive directors.</p>\n<p>Executive directors are Dr. Zhao Jianhui and Ms. Pan Menghan. The non-executive cohort consists of Ms. Xie Jieping and Ms. Guo Danxia. Independent oversight is provided by Dr. Kang Junyong, Dr. Liao Yi and Dr. Su Xinlong.</p>\n<p>Committee leadership and membership have been clarified:</p>\n<p>• Audit Committee – chaired by Dr. Su Xinlong, with Dr. Kang Junyong and Dr. Liao Yi serving as members.  \n• Remuneration Committee – chaired by Dr. Kang Junyong; members include Ms. Pan Menghan and Dr. Su Xinlong.  \n• Nomination Committee – chaired by Dr. Liao Yi and joined by Dr. Kang Junyong and Dr. Su Xinlong.  \n• Strategy Committee – chaired by Dr. Zhao Jianhui, with Ms. Guo Danxia serving as a member.</p>\n<p>The announcement underscores EPIWORLD’s adherence to corporate governance practices by delineating clear responsibilities across its audit, remuneration, nomination and strategy functions. The disclosure satisfies Hong Kong listing requirements for transparency regarding board roles and committee composition.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02726","symbol_name":"瀚天天成","start_time":0,"source_url":"","article_id":"1116120637","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116120637","pubTimestamp":1782140597,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Epiworld International Co., Ltd. disclosed the latest structure of its Board of Directors and subsidiary committees on 22 June 2026. The Board now comprises seven members: two executive directors,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02726":"瀚天天成"},"translate_title":"EPIWORLD发布最新的董事会组成和委员会任务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02726":1},"content_text":"Epiworld International Co., Ltd. disclosed the latest structure of its Board of Directors and subsidiary committees on 22 June 2026. The Board now comprises seven members: two executive directors, two non-executive directors and three independent non-executive directors.\nExecutive directors are Dr. Zhao Jianhui and Ms. Pan Menghan. The non-executive cohort consists of Ms. Xie Jieping and Ms. Guo Danxia. Independent oversight is provided by Dr. Kang Junyong, Dr. Liao Yi and Dr. Su Xinlong.\nCommittee leadership and membership have been clarified:\n• Audit Committee – chaired by Dr. Su Xinlong, with Dr. Kang Junyong and Dr. Liao Yi serving as members.  \n• Remuneration Committee – chaired by Dr. Kang Junyong; members include Ms. Pan Menghan and Dr. Su Xinlong.  \n• Nomination Committee – chaired by Dr. Liao Yi and joined by Dr. Kang Junyong and Dr. Su Xinlong.  \n• Strategy Committee – chaired by Dr. Zhao Jianhui, with Ms. Guo Danxia serving as a member.\nThe announcement underscores EPIWORLD’s adherence to corporate governance practices by delineating clear responsibilities across its audit, remuneration, nomination and strategy functions. The disclosure satisfies Hong Kong listing requirements for transparency regarding board roles and committee composition.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1116120637","isCrawlerRequest":true}